Establishment of small molecule-based in silico models for prediction of hERG and Nav1.5 inhibitions for drug discovery

被引:0
|
作者
Kawada, Megumi Ikemori [1 ]
Dodo, Tetsushi [1 ]
Yu, Melvin [2 ]
Yoshinaga, Takashi [1 ]
Inoue, Atsushi [1 ]
Sawada, Kohei [1 ]
机构
[1] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan
[2] Eisai Inc, Andover, MA USA
关键词
D O I
10.1016/j.toxlet.2014.06.554
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
P-3.44
引用
收藏
页码:S161 / S161
页数:1
相关论文
共 9 条
  • [1] Basic approach to optimize the small drug seeds with minimized CV risks on the early stage of drug discovery by using small molecule-based in silico models for prediction of hERG/Nav1.5 inhibitions
    Dodo, Tetsushi
    Kawada, Megumi Ikemori
    Yu, Melvin
    Yoshinaga, Takashi
    Inoue, Atsushi
    Sawada, Kohei
    [J]. TOXICOLOGY LETTERS, 2014, 229 : S159 - S159
  • [2] Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction
    Arab, Issar
    Egghe, Kristof
    Laukens, Kris
    Chen, Ke
    Barakat, Khaled
    Bittremieux, Wout
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 64 (07) : 2515 - 2527
  • [3] Semisupervised Learning to Boost hERG, Nav1.5, and Cav1.2 Cardiac Ion Channel Toxicity Prediction by Mining a Large Unlabeled Small Molecule Data Set
    Arab, Issar
    Laukens, Kris
    Bittremieux, Wout
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (16) : 6410 - 6420
  • [4] Identification of cardiac liability in drug discovery using automated patch clamp: experimental and technical considerations for high throughput recordings of NaV1.5 and hERG
    Rotordam, Maria Giustina
    Obergrussberger, Alison
    Brinkwirth, Nina
    Takasuna, Kiyoshi
    Becker, Nadine
    Horvath, Andras
    Furukawa, Hatsue
    Hasegawa, Yuka
    Oka, Takayuki
    Fertig, Niels
    Stoelzle-Feix, Sonja
    [J]. BIOPHYSICAL JOURNAL, 2022, 121 (03) : 503A - 503A
  • [5] Reliable identification of cardiac liability in drug discovery using automated patch clamp: Experimental and technical considerations for high throughput recordings of NaV1.5 and hERG
    Rotordam, Maria Giustina
    Obergrussberger, Alison
    Brinkwirth, Nina
    Takasuna, Kiyoshi
    Becker, Nadine
    Horvath, Andras
    Furukawa, Hatsue
    Hasegawa, Yuka
    Oka, Takayuki
    Fertig, Niels
    Stoelzle-Feix, Sonja
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2022, 117
  • [6] Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies
    Moshawih, Said
    Lim, Ai Fern
    Ardianto, Chrismawan
    Goh, Khang Wen
    Kifli, Nurolaini
    Goh, Hui Poh
    Jarrar, Qais
    Ming, Long Chiau
    [J]. BIOMOLECULES, 2022, 12 (07)
  • [7] Discovery of Novel STAT3 Small Molecule Inhibitors via in Silico Site-Directed Fragment-Based Drug Design
    Yu, Wenying
    Xiao, Hui
    Lin, Jiayuh
    Li, Chenglong
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (11) : 4402 - 4412
  • [8] Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design
    Yu, Wenying
    Lin, Jiayuh
    Li, Chenglong
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [9] Discovery of potential PD-L1 small molecule inhibitors as novel cancer therapeutics using machine learning-based QSAR models: A virtual drug repurposing study
    Siyah, Pinar
    Durdagi, Serdar
    Aksoydan, Busecan
    [J]. BIOPHYSICAL JOURNAL, 2023, 122 (03) : 144A - 144A